Biden to Announce Purchase of 100 Million Additional J&J Vaccines

Mandatory Credit: Photo by Kevin Dietsch/UPI/Shutterstock (11791841q)President Joe Biden listens as Vice President Kamala Harris delivers remarks at a Combatant Commander nomination event for, Air Force Gen.
Kevin Dietsch/UPI/Shutterstock / Kevin Dietsch/UPI/Shutterstock

President Joe Biden is set to announce today that the U.S. will buy an additional 100 million doses of the single-dose Johnson & Johnson COVID vaccine, NBC News reports, citing two sources in the administration.

See: Biden Moves Up Vaccine Timeline, Announces Major Corporate Partners in ‘Wartime Effort’
Find: Will Vaccinations Lead to Vaxications?

Biden will make the announcement this afternoon during a meeting with the CEOs of Johnson & Johnson and Merck, according to NBC News. This will likely give the U.S. enough vaccines to inoculate the entire population.

Just last week, Biden announced the “type of collaboration between companies we saw in World War Two,” with two competitors working together. Merck will help Johnson & Johnson produce its COVID vaccine, bringing the country “on track to have enough vaccine supply for every adult in America by the end of May,” he said in a briefing.

Biden added that his administration had also invoked the Defense Production Act to equip two Merck facilities to the standards necessary to safely manufacture the J&J vaccine. “I’ve always said, this was a wartime effort, and every action has been on the table, including putting together breakthrough approaches,” Biden said.

See: Who Is Getting Vaccines? Survey Notes Income Disparity in Vaccine Recipients
Find: Biden to Invest $4 Billion in Global Vaccine Effort

Make Your Money Work for You

“And with the urging and assistance of my administration, Johnson & Johnson is also taking additional new actions to safely accelerate vaccine production. Johnson & Johnson’s vaccine manufacturing facilities will now begin to operate 24/7,” he said.

Johnson & Johnson’s single-dose COVID-19 vaccine was granted emergency use authorization by the Food and Drug Administration on Feb. 28. Johnson & Johnson’s vaccine, the Janssen Biotech Inc. COVID-19 Vaccine, is the third — after Moderna and Pfizer — to be granted an EUA and the first one requiring only one dose, facilitating and accelerating distribution amid a rollout that has been less than seamless.

At her daily press briefing yesterday, Press Secretary Jen Psaki said that “it’s important to remember only about 10% of the American population is vaccinated at this point. We’ve obviously made progress, but we have more work to do. And right now, our focus, as the U.S. government, is on getting more people vaccinated.”

More from GOBankingRates

About the Author

Yaël Bizouati-Kennedy is a former full-time financial journalist and has written for several publications, including Dow Jones, The Financial Times Group, Bloomberg and Business Insider. She also worked as a vice president/senior content writer for major NYC-based financial companies, including New York Life and MSCI. Yaël is now freelancing and most recently, she co-authored  the book “Blockchain for Medical Research: Accelerating Trust in Healthcare,” with Dr. Sean Manion. (CRC Press, April 2020) She holds two master’s degrees, including one in Journalism from New York University and one in Russian Studies from Université Toulouse-Jean Jaurès, France.

Untitled design (1)
Close popup The GBR Closer icon

Sending you timely financial stories that you can bank on.

Sign up for our daily newsletter for the latest financial news and trending topics.

Loading...
Please enter an email.
Please enter a valid email address.
There was an unknown error. Please try again later.

For our full Privacy Policy, click here.